featured expert Kevin Matras highlights: Cognex, Fresh Del Monte and Xilinx

Kevin Matras explains why the market looks so 'cheap' and how to start planning your market-bottoming purchases. Stocks in this weeks article are Cognex Corporation (NASDAQ: CGNX), Fresh Del Monte (NYSE: FDP) and Xilinx, Inc. (NASDAQ: XLNX). Click here for the full story exclusively on

Screen of the Week written by Kevin Matras of Zacks Investment Research:

This week Im writing about the value of the market.

First, I know everyone is debating whether or not were in a recession. No need to debate. I have the answer: Were not. Were in a short-term economic slowdown and the economy is still growing. With the dramatic interest rate cuts (with more possibly to follow), along with the stimulus checks, ordinary tax refunds and tax breaks for business; most economists believe the economy will be looking good in the second half.

Secondly, people are now talking about stagflation. No need to talk about it. Were not in it. In fact, at the moment were nowhere close to its historical measures. Last time we had stagflation; inflation was in the double digits, and unemployment was at 8.5%. Currently, inflation is at 2.7% and unemployment is only at 4.6%.

Now let me switch gears. People are wondering if were at a market bottom. For this one, Id say were darn close. For many stocks, its already happened. There are plenty of great stocks firmly entrenched in strong uptrends, and theres no shortage of stocks making new 52-week highs.

Heres where the cheap part comes into play. First, excluding Financials, I looked at the median projected quarter-over-same-quarter-a-year-ago period for companies in the S&P 500, and found that the estimated growth rate was 9.4%. (Even with the Financials included, it was still 7.7%.) Thats pretty good.

Then I decided to see how the P/Es stacked up to their 5-Year High P/E ratios and their 5-Year Average P/E ratios. Thats when I realized how cheap this market really is.

P/E ratios are more than 18% lower than their 5-Year average and more than 41% off of their 5-Year High.

So what to do?

Im running screens right now that are showing solid earnings forecasts (Qtr-over-same-Qtr-a-year-ago), growth rates better than their 5-Year Average and that are trading at P/Es more than 40% below their 5-Year Average.

* Est. EPS Growth Q(1)/Q(-3) greater than or equal to 10


* Est. EPS Growth Rate F(1)/F(0) greater than or equal to 5 Yr. Avg. Historical Growth Rate

* PE / 5 Yr. Avg. PE less than or equal to .60

(i.e., PEs more than 40% below their 5 Yr. avg.)

Here are a few stocks that passed this screen:

CGNX Cognex Corp.

FDP Fresh Del Monte

XLNX Xilinx, Inc.

Discover all the stocks on this list and start finding winners on your own. You can do it. Sign up now for your free trial to the Research Wizard:

Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.

About Screen of the Week created the first and best screening system on the web earning the distinction as the "#1 site for screening stocks" by Money Magazine. But powerful screening tools is just the start. That is why Zacks created the Screen of the Week to highlight profitable stock picking strategies that investors can actively use. Each week, Zacks Profit from the Pros free email newsletter shares a new screening strategy. Learn more about it here

About Zacks is a property of Zacks Investment Research, Inc., which was formed in 1978 by Leonard Zacks. As a PhD in mathematics Len knew he could find patterns in stock market data that would lead to superior investment results. Amongst his many accomplishments was the formation of his proprietary stock picking system; the Zacks Rank, which continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

The performance calculations for the Research Wizard strategies were produced through the backtesting feature of the Research Wizard using the DBCMHIST database and consist of the total return (price changes + dividends) of an equal weighted portfolio. Returns are calculated on a specified periodic basis (most often one or four weeks) and assume no transaction costs. The portfolio is rebalanced at the start of each new period. Returns can be stated as either annualized or compounded.

Stock trading/investing involves risk and you can lose some or all of your investment. Hypothetical or backtested results may not always be duplicated in the real world. Backtesting can at times produce an unintended look-ahead bias. Results can also at times be over or understated due to the exclusion of inactive companies. In addition, hypothetical trading does not involve financial risk, and no hypothetical trading record can completely account for the impact of financial risk in actual trading, not the least of which is the ability to withstand losses or to adhere to a particular trading strategy in spite of trading losses. These are material points which can also adversely affect actual trading results. The backtested results prepared for the Zacks Method were done using the DBCMHIST database and consisted of only active companies. The Research Wizard program has been aligned, to the extent possible, to eliminate look-ahead bias. Zacks however cannot make any guarantees in regard to this or any other possible limitation.

For more information, please visit

Contact: Jim Giaquinto
Phone: 312-265-9268

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.